First Time Loading...

Adimmune Corp
TWSE:4142

Watchlist Manager
Adimmune Corp Logo
Adimmune Corp
TWSE:4142
Watchlist
Price: 27.05 TWD Market Closed
Updated: Apr 28, 2024

Wall Street
Price Targets

Price Targets Summary
Adimmune Corp

Wall Street analysts forecast Adimmune Corp stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Adimmune Corp is 35 TWD .

Lowest
Price Target
Not Available
Average
Price Target
35 TWD
29% Upside
Highest
Price Target
Not Available
Adimmune Corp Competitors:
Price Targets
397030
AprilBio Co Ltd
83% Upside
ADMA
ADMA Biologics Inc
30% Upside
PRAX
Praxis Precision Medicines Inc
158% Upside
TLX
Telix Pharmaceuticals Ltd
2% Upside
MGNX
MacroGenics Inc
74% Upside
4893
Noile-Immune Biotech Inc
159% Upside
NYKD
Nykode Therapeutics ASA
208% Upside
1530
3SBio Inc
27% Upside

Revenue
Forecast

Revenue Estimate
Adimmune Corp

For the last 8 years the compound annual growth rate for Adimmune Corp's revenue is 25%. The projected CAGR for the next 1 year is 63%.

25%
Past Growth
63%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Adimmune Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
25%
Average Beat

Net Income
Forecast

Net Income Estimate
Adimmune Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Adimmune Corp's stock price target?
Price Target
35 TWD

According to Wall Street analysts, the average 1-year price target for Adimmune Corp is 35 TWD .

What is Adimmune Corp's Revenue forecast?
Projected CAGR
63%

For the last 8 years the compound annual growth rate for Adimmune Corp's revenue is 25%. The projected CAGR for the next 1 year is 63%.